Rare diseases
Investigational molecules
Locations
278 conditions with trials, the busiest first
677 trials across Europe, recruiting first
Rimonabant for Improving Cognitive Impairment in Patients with Post‑COVID‑19 Syndrome: A Randomized, Placebo‑Controlled Trial
SpainStudy of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years
BelgiumEffectiveness of a second dose of RSV subgroup A 847A and subgroup B 847B versus primary dose to prevent respiratory syncytial virus infection in immunocompromised adults
DenmarkSafety and Immune Response of GBS‑NN/NN2 Vaccine in Pregnant Women and Their Infants to Prevent Group B Streptococcus Infection
BelgiumImmune response and safety of investigational MMRV vaccine (GSKVX000000025896) drug combination compared with standard MMRV vaccine in healthy children 15 months to 6 years
GermanySafety and immune response of OVX836C2 vaccine compared with drug combination in healthy adults with influenza
BelgiumCloxacillin and drug combination for prevention of postoperative infections in patients undergoing head and neck reconstructive surgery
DenmarkEfficacy and Safety of Amara‑Tropfen Dilution vs Placebo in Patients with Irritable Bowel Syndrome
GermanyComparison of ampicillin plus gentamicin versus piperacillin/tazobactam for empirical treatment of hospitalized patients with community‑acquired infection
DenmarkDiagnostic PET Study of Al[18F]F-NOTA-folate in Patients with Suspected Cardiac Sarcoidosis or Infective Endocarditis
FinlandIntravenous benzathine benzylpenicillin added to oral phenoxymethylpenicillin for relief in adults with acute tonsillitis, peritonsillar phlegmon and abscess
DenmarkFosfomycin trometamol versus drug combination for treating acute E. coli pyelonephritis in women aged 75 years and older
FranceThe therapies tested most often in Infections and infestations trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
